|
|
ANSTO Publications Online >
Browsing by Author Katsifis, A
Showing results 1 to 20 of 33
| Issue Date | Title | Author(s) | | 1-Dec-2010 | Activation of signal pathways and the resistance to anti-EGFR treatment in colorectal cancer. | Chen, JZ; Huang, XF; Katsifis, A |
| 12-May-2008 | Alternative method for Cu-64 radioisotope production. | Le, VS; Howse, J; Zaw, M; Pellegrini, P; Katsifis, A; Greguric, I; Weiner, R |
| 1-Jan-2012 | Automated radiosynthesis of [18F]PBR111 and [18F]PBR102 using the TracerLab FXFN and TracerLab MXFDG module for imaging the peripheral benzodiazepine receptor with PET | Bourdier, T; Pham, T Q; Henderson, D; Jackson, T; Lam, P; Izard, M; Katsifis, A |
| 1-Dec-2011 | Clusterin facilitates in vivo clearance of extracellular misfolded proteins. | Wyatt, A R; Yerbury, J J; Berghofer, P; Greguric, I; Katsifis, A; Dobson, C M; Wilson, M R |
| Jan-2015 | Comparison of in vivo binding properties of the 18-kDa translocator protein (TSPO) ligands [18F]PBR102 and [18F]PBR111 in a model of excitotoxin-induced neuroinflammation | Callaghan, PD; Wimberley, CA; Rahardjo, GL; Berghofer, PJ; Pham, TQ; Jackson, T; Zahra, D; Bourdier, T; Wyatt, N; Greguric, I; Howell, NR; Siegele, R; Pastuovic, Z; Mattner, F; Loc’h, C; Gregoire, MC; Katsifis, A |
| 26-Mar-2007 | Decreased vesicular acetylcholine transporter and α4β2 nicotinic receptor density in the rat brain following 192 IgG-saporin immunolesioning | Quinlivan, M; Chalon, S; Vergote, J; Henderson, J; Katsifis, A; Kassiou, M; Guilloteau, D |
| 1-Dec-2010 | Detection and quantification of remote microglial activation in rodent models of focal ischaemia using the TSPO radioligand CLINDE. | Arlicot, N; Petit, E; Katsifis, A; Toutain, J; Divoux, D; Bodard, S; Roussel, S; Guilloteau, D; Bernaudin, M; Chalon, S |
| 29-Jun-2007 | Detection of apoptotic cell death in the thymus of dexamethasone treated rats using [123I]Annexin V and in situ oligonucleotide ligation | Zavitsanou, K; Nguyen, VH; Greguric, I; Chapman, J; Ballantyne, P; Katsifis, A |
| 11-Oct-2010 | Development of [18F]-Flumazenil-PET for localisation of the epileptogenic zone in patients with medically refractory focal epilepsy. | Vivash, L; Gregoire, M; Dedeurwaerdere, S; Bouilleret, V; Roselt, P; Lau, EW; Ware, RE; Binns, D; Katsifis, A; Hicks, RJ; Myers, DE; O'Brien, TJ |
| 1-May-2011 | Differential behavioural and neurochemical outcomes from chronic paroxetine treatment in adolescent and adult rats: a model of adverse antidepressant effects in human adolescents? | Karanges, E; Li, K; Motbey, C; Callaghan, P; Katsifis, A; McGregor, I |
| 10-Sep-2009 | Discovery of [F-18]N-(2-(Diethylamino)ethyl)-6-fluoronicotinamide: a melanoma positron emission tomography imaging radiotracer with high tumor to body contrast ratio and rapid renal clearance. | Greguric, I; Taylor, SR; Denoyer, D; Ballantyne, P; Berghofer, P; Roselt, P; Pham, TQ; Mattner, F; Bourdier, T; Neels, OC; Dorow, DS; Loc'h, C; Hicks, RJ; Katsifis, A |
| 1-Aug-2011 | Evaluation of [I-123]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation. | Mattner, F; Bandin, D L; Staykova, M; Berghofer, P; Gregoire, M-C; Ballantyne, P; Quinlivan, M; Fordham, S; Pham, T; Willenborg, D O; Katsifis, A |
| Mar-2010 | High-contrast PET of melanoma using F-18-MEL050, a selective probe for melanin with predominantly renal clearance. | Denoyer, D; Greguric, I; Roselt, P; Neels, OC; Aide, N; Taylor, SR; Katsifis, A; Dorow, DS; Hicks, RJ |
| 1-Jan-2011 | Improved detection of regional melanoma metastasis using 18F-6-Fluoro-N-[2-(Diethylamino)Ethyl] Pyridine-3-Carboxamide, a Melanin-specific PET probe, by perilesional administration. | Denoyer, D; Potdevin, T; Roselt, P; Neels, OC; Kirby, L; Greguric, I; Katsifis, A; Dorow, DS; Hicks, RJ |
| 1-May-2010 | In vivo imaging of neuroinflammation: a comparative study between [F-18]PBR111, [C-11]CLINME and [C-11]PK11195 in an acute rodent model. | Van Camp, N; Boisgard, R; Kuhnast, B; Thézé, B; Viel, T; Grégoire, M C; Chauveau, F; Boutin, H; Katsifis, A; Dolle, F; Tavitian, B |
| 1-Jul-2011 | In vivo pharmacokinetics of radioiodinated urokinase plasminogen activator (uPA) inhibitors for imaging metastatic cancer. | Berghhofer, P; Greguric, I; Shepherd, R; Katsifis, A; Ranson, M; Vine, K |
| Jun-2009 | In-vivo imaging characteristics of two fluorinated flumazenil radiotracers in the rat. | Dedeurwaerdere, S; Gregoire, MC; Vivash, L; Roselt, P; Binns, D; Fookes, C; Greguric, I; Pham, T; Loc'h, C; Katsifis, A; Hicks, RJ; O'Brien, TJ; Myers, DE |
| 1-Jun-2011 | Insulin decreases therapeutic efficacy in colon cancer cell line HT29 via the activation of the PI3K/Akt pathway. | Chen, J; Katsifis, A; Hu, C; Huang, X-F |
| 11-Oct-2010 | Metabolism of CLINDE, a peripheral benzodiazepine receptor SPECT ligand. | Peyronneau, M; Mattner, F; Howell, N; Jiang, C; Pelegrini, P; Greguric, I; Loch, C; Katsifis, A |
| 16-Sep-2013 | One‐step radiosynthesis of 4‐nitrophenyl 2‐[18F]fluoropropionate ([18F]NFP); improved preparation of radiolabeled peptides for PET imaging | Haskali, M; Roselt, PD; Karas, JA; Noonan, W; Wichmann, CW; Katsifis, A; Hicks, RJ; Hutton, CA |
Showing results 1 to 20 of 33
|
